
New Medicare benefit available for kidney recipients
Beginning Jan. 1, 2023, this new benefit helps cover the costs for immunosuppressive drugs beyond 36 months after transplant for patients with ESRD.
Beginning Jan. 1, 2023, this new benefit helps cover the costs for immunosuppressive drugs beyond 36 months after transplant for patients with ESRD.
We’ve put together some frequently asked questions to help patients wondering about the upcoming change.
This policy change is intended to more accurately reflect patient sensitization.
With the newly updated data, transplant programs can better understand how their Offer Filters would have affected the number of offers received recently.
All adult kidney programs will be able to evaluate organ offers using predictive data.
OPOs are now required to make a reasonable effort to perform renal procurement biopsies for deceased kidney donors meeting certain criteria.